Estrogen deficiency results in apoptosis in the frontal cortex of adult female aromatase knockout mice

Molecular and Cellular Neuroscience

Volumn 41, Issue 1, 2009, Pages 1-7

  Hill, Rachel A ^a   Chua, Hui Kheng ^b   Jones, Margaret E E ^a   Simpson, Evan R ^a   Boon, Wah Chin ^a,b  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Apoptosis; Aromatase; Brain; Estrogen; Female; Frontal cortex; Knockout mouse

Indexed keywords

AROMATASE; ESTRADIOL; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; BRAIN WEIGHT; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ESTROGEN DEFICIENCY; FEMALE; FRONTAL CORTEX; GENE CONTROL; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SEX DIFFERENCE; UPREGULATION; WILD TYPE;

ANIMALS; APOPTOSIS; AROMATASE; CASPASE 3; CELL SURVIVAL; ESTRADIOL; ESTROGENS; FEMALE; FRONTAL LOBE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; ORGAN SIZE;

MUS;

EID: 64849110620     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2008.12.009     Document Type: Article

References (67)

1. Amantea D., Russo R., Bagetta G., and Corasaniti M.T. From clinical evidence to molecular mechanisms underlying neuroprotection afforded by estrogens. Pharmacol. Res. 52 (2005) 119-132
2. Azcoitia I., Sierra A., Veiga S., Honda S., Harada N., and Garcia-Segura L.M. Brain aromatase is neuroprotective. J. Neurobiol. 47 (2001) 318-329
3. Bakker J., Honda S.I., Harada N., and Balthazart J. The aromatase knock-out mouse provides new evidence that estradiol is required during development in the female for the expression of sociosexual behaviors in adulthood. J. Neurosci. 22 (2002) 9104-9112
4. Balthazart J., Foidart A., Surlemont C., and Harada N. Distribution of Aromatase-Immunoreactive Cells in the Mouse Forebrain. Cell Tissue Res. 263 (1991) 71-79
5. Belcredito S., Brusadelli A., and Maggi A. Estrogens, apoptosis and cells of neural origin. J. Neurocytol. 29 (2000) 359-365
6. Boon W.C., Diepstraten J., van der B.J., Jones M.E., Simpson E.R., and van den B.M. Hippocampal NMDA receptor subunit expression and watermaze learning in estrogen deficient female mice. Brain Res. Mol. Brain Res. 140 (2005) 127-132
7. Carlson L.E., and Sherwin B.B. Steroid hormones, memory and mood in a healthy elderly population. Psychoneuroendocrinology 23 (1998) 583-603
8. Cheng, C. and Zochodne, D.W., 2003 Sensory neurons with activated caspase-3 survive long-term experimental diabetes 52, 2363-2371.
9. Craig M.C., Maki P.M., and Murphy D.G.M. The women's health initiative memory study: findings and implications for treatment. Lancet Neurol. 4 (2005) 190-194
10. Cyr M., Calon F., Morissette M., and Di Paolo T. Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease. J. Psychiatry Neurosci. 27 (2002) 12-27
11. Dalla C., Antoniou K., Papadopoulou-Daifoti Z., Balthazart J., and Bakker J. Oestrogen-deficient female aromatase knockout (ArKO) mice exhibit depressive-like symptomatology. Eur. J. Neurosci. 20 (2004) 217-228
12. Dubal D.B., Shughrue P.J., Wilson M.E., Merchenthaler I., and Wise P.M. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J. Neurosci. 19 (1999) 6385-6393
13. Dubal D.B., Zhu H., Yu J., Rau S.W., Shughrue P.J., Merchenthaler I., Kindy M.S., and Wise P.M. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1952-1957
14. Duff S.J., and Hampson E. A beneficial effect of estrogen on working memory in postmenopausal women taking hormone replacement therapy. Horm. Behav. 38 (2000) 262-276
15. Fisher C.R., Graves K.H., Parlow A.F., and Simpson E.R. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6965-6970
16. Fluck E., File S.E., and Rymer J. Cognitive effects of 10 years of hormone-replacement therapy with tibolone. J. Clin. Psychopharmacol. 22 (2002) 62-67
17. Foidart A., Harada N., and Balthazart J. Aromatase-immunoreactive cells are present in mouse brain areas that are known to express high levels of aromatase activity. Cell Tissue Res. 280 (1995) 561-574
18. Fukuda K., Yao H., Ibayashi S., Nakahara T., Uchimura H., Fujishima M., and Hall E.D. Ovariectomy exacerbates and estrogen replacement attenuates photothrombotic focal ischemic brain injury in rats. Stroke 31 (2000) 155-160
19. Garcia-Segura L.M., Azcoitia I., and DonCarlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 63 (2001) 29-60
20. Gibbs R.B. Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol. Aging 21 (2000) 107-116
21. Gilmore E.C., Nowakowski R.S., Caviness Jr. V.S., and Herrup K. Cell birth, cell death, cell diversity and DNA breaks: how do they all fit together?. Trends Neurosci. 23 (2000) 100-105
22. Gollapudi L., and Oblinger M.M. Estrogen and NGF synergistically protect terminally differentiated, ERalpha-transfected PC12 cells from apoptosis. J. Neurosci. Res. 56 (1999) 471-481
23. Hill R.A., Pompolo S., Jones M.E., Simpson E.R., and Boon W.C. Estrogen deficiency leads to apoptosis in dopaminergic neurons in the medial preoptic area and arcuate nucleus of male mice. Mol. Cell. Neurosci. 27 (2004) 466-476
24. Hill R.A., Chow J.D.Y., Hillisch A., Jones M.E.E., Simpson E.R., and Boon W.C. Fas/FasL mediated apoptosis in the arcuate nucleus and medial preoptic area of male ArKO mice is ameliorated by selective Estrogen Receptor alpha and beta agonist treatment respectively. Mol. Cell. Neurosci. 36 (2007) 146-157
25. Honda K., Shimohama S., Sawada H., Kihara T., Nakamizo T., Shibasaki H., and Akaike A. Nongenomic antiapoptotic signal transduction by estrogen in cultured cortical neurons. J. Neurosci. Res. 64 (2001) 466-475
26. Hojo Y., Hattori T.A., Enami T., Furukawa A., Suzuki K., Ishii H.T., Mukai H., Morrison J.H., Janssen W.G., Kominami S., Harada N., Kimoto T., and Kawato S. Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017alpha and P450 aromatase localized in neurons. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 865-870
27. Hosoda T., Nakajima H., and Honjo H. Estrogen protects neuronal cells from amyloid beta-induced apoptotic cell death. NeuroReport 12 (2001) 1965-1970
28. Hsu H., Xiong J., and Goeddel D.V. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 19 81 (1995) 495-504
29. Jakab R.L., Harada N., and Naftolin F. Aromatase- (estrogen synthetase) immunoreactive neurons in the rat septal area. A light and electron microscopic study. Brain Res. 664 (1994) 85-93
30. Joffe H., Hall J.E., Gruber S., Sarmiento I.A., Cohen L.S., Yurgelun-Todd D., and Martin K.A. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause 13 (2006) 411-422
31. Kajta M., Budziszewska B., Marszal M., and Lason W. Effects of 17-beta estradiol and estriol on NMDA-induced toxicity and apoptosis in primary cultures of rat cortical neurons. J. Physiol. Pharmacol. 52 (2001) 437-446
32. Krug R., Born J., and Rasch B. A 3-day estrogen treatment improves prefrontal cortex-dependent cognitive function in postmenopausal women. Psychoneuroendocrinology 31 (2006) 965-975
33. Lephart E.D., Lund T.D., and Horvath T.L. Brain androgen and progesterone metabolizing enzymes: biosynthesis, distribution and function. Brain Res. Brain Res. Rev. 37 (2001) 25-37
34. Maki, P.M., 2005. A systematic review of clinical trials of hormone therapy on cognitive function - effects of age at initiation and progestin use. Future of hormone therapy: what basic science and clinical studies teach us 1052, 182-197.
35. Maki P.M., Gast M.J., Vieweg A.J., Burriss S.W., and Yaffe K. Hormone therapy in menopausal women with cognitive complaints - a randomized, double-blind trial. Neurology 69 (2007) 1322-1330
36. Martin S., Jones M., Simpson E., and van den Buuse M. Impaired spatial reference memory in aromatase-deficient (ArKO) mice. NeuroReport 14 (2003) 1979-1982
37. McCullough L.D., Blizzard K., Simpson E.R., Oz O.K., and Hurn P.D. Aromatase cytochrome P450 and extragonadal estrogen play a role in ischemic neuroprotection. J. Neurosci. 23 (2003) 8701-8705
38. Miller M.M., Hyder S.M., Assayag R., Panarella S.R., Tousignant P., and Franklin K.B. Estrogen modulates spontaneous alternation and the cholinergic phenotype in the basal forebrain. Neuroscience 91 (1999) 1143-1153
39. Moosmann B., and Behl C. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 8867-8872
40. Morissette M., Al Sweidi S., Callier S., and Di Paolo T. Estrogen and SERM neuroprotection in animal models of Parkinson's disease. Mol. Cell. Endocrinol. 290 (2008) 60-69
41. Morris R.G., Garrud P., Rawlins J.N., and O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 297 (1982) 681-683
42. Owen A.M. The functional organization of working memory processes within human lateral frontal cortex: the contribution of functional neuroimaging. Eur. J. Neurosci 9 (1997) 1329-1339
43. Paxinos G., and Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates: Compact Second (2004), Edition Academic Press
44. Petrides M. Impairments on nonspatial self-ordered and externally ordered working memory tasks after lesions of the mid-dorsal part of the lateral frontal cortex in the monkey. J. Neurosci. 15 (1995) 359-375
45. Petrides M. Impairments in working memory after frontal cortical excisions. Adv. Neurol. 84 (2000) 111-118
46. Pike C.J. Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. J. Neurochem. 72 (1999) 1552-1563
47. Postle B.R., Berger J.S., Taich A.M., and D'Esposito M. Activity in human frontal cortex associated with spatial working memory and saccadic behavior. J. Cogn. Neurosci. 12 Suppl 2 (2000) 2-14
48. Ranger A.M., Malynn B.A., and Korsmeyer S.J. Mouse models of cell death. Nat. Genet. 28 (2001) 113-118
49. Rapp S.R., Espeland M.A., Shumaker S.A., Henderson V.W., Brunner R.L., Manson J.E., Gass M.L., Stefanick M.L., Lane D.S., Hays J., Johnson K.C., Coker L.H., Dailey M., and Bowen D. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289 (2003) 2663-2672
50. Raz N., Gunning F.M., Head D., Dupuis J.H., McQuain J., Briggs S.D., Loken W.J., Thornton A.E., and Acker J.D. Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. Cereb. Cortex 7 (1997) 268-282
51. Reddien P.W., Cameron S., and Horvitz H.R. Phagocytosis promotes programmed cell death in C. elegans. Nature 412 (2001) 198-202
52. Robertson K.M., O'Donnell L., Jones M.E., Meachem S.J., Boon W.C., Fisher C.R., Graves K.H., McLachlan R.I., and Simpson E.R. Impairment of spermatogenesis in mice lacking a functional aromatase (Cyp19) gene. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 7986-7991
53. Roof R.L., and Hall E.D. Estrogen-related gender difference in survival rate and cortical blood flow after impact-acceleration head injury in rats. J. Neurotrauma 17 (2000) 1155-1169
54. Salat D.H., Kaye J.A., and Janowsky J.S. Selective preservation and degeneration within the prefrontal cortex in aging and Alzheimer disease. Arch. Neurol. 58 (2001) 1403-1408
55. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L., Jones III B.N., Assaf A.R., Jackson R.D., Kotchen J.M., Wassertheil-Smoller S., and Wactawski-Wende J. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289 (2003) 2651-2662
56. Smith Y.R., Love T., Persad C.C., Tkaczyk A., Nichols T.E., and Zubieta J.K. Impact of combined estradiol and norethindrone therapy on visuospatial working memory assessed by functional magnetic resonance imaging. J. Clin. Endocrinol. Metabolism 91 (2006) 4476-4481
57. Stephens C., Bristow V., and Pachana N.A. HRT and everyday memory at menopause: a comparison of two samples of mid-aged women. Women Health 43 (2006) 37-57
58. Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., and Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348 (1996) 429-432
59. Vaucher E., Reymond I., Najaffe R., Kar S., Quirion R., Miller M.M., and Franklin K.B. Estrogen effects on object memory and cholinergic receptors in young and old female mice. Neurobiol. Aging 23 (2002) 87-95
60. Wagner C.K., and Morrell J.I. Neuroanatomical distribution of aromatase MRNA in the rat brain: indications of regional regulation. J. Steroid Biochem. Mol. Biol. 61 (1997) 307-314
61. Wallace M., Luine V., Arellanos A., and Frankfurt M. Ovariectomized rats show decreased recognition memory and spine density in the hippocampus and prefrontal cortex. Brain Res. 1126 (2006) 176-182
62. Wang L., Andersson S., Warner M., and Gustafsson J.A. Morphological abnormalities in the brains of estrogen receptor beta knockout mice. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 2792-2796
63. Wise P.M., Dubal D.B., Wilson M.E., Rau S.W., Bottner M., and Rosewell K.L. Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies. Brain Res. Brain Res. Rev. 37 (2001) 313-319
64. Xu H., Wang R., Zhang Y.W., and Zhang X. Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease. Ann. N. Y. Acad. Sci. 1089 (2006) 324-342
65. Yue X., Lu M., Lancaster T., Cao P., Honda S., Staufenbiel M., Harada N., Zhong Z., Shen Y., and Li R. Brain estrogen deficiency accelerates A{beta} plaque formation in an Alzheimer's disease animal model. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 19198-19203
66. Zhao L., Wu T.W., and Brinton R.D. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res. 1010 (2004) 22-34
67. Zong W.X., Edelstein L.C., Chen C., Bash J., and Gelinas C. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev. 13 (1999) 382-387